By Mill Chart
Last update: Dec 7, 2023
Our stockscreener has identified a possible breakout setup on ABBOTT LABORATORIES (NYSE:ABT). This occurs when the stock consolidates following a significant upward movement. While the breakout outcome cannot be guaranteed, it may be worth monitoring NYSE:ABT for potential opportunities.
Every day ChartMill assigns a Technical Rating to every stock. The score ranges from 0 to 10 and is determined by evaluating multiple technical indicators and properties.
We assign a technical rating of 7 out of 10 to ABT. ABT has been a medium performer in the overall market. Some doubts are observed in the medium time frame, but recent action was very positive.
Our latest full technical report of ABT contains the most current technical analsysis.
ChartMill incorporates a Setup Rating in its analysis, which measures the extent of consolidation in a stock over recent days and weeks. This rating, ranging from 0 to 10, is updated daily and takes into account multiple short-term technical indicators. The current setup rating for NYSE:ABT is 8:
ABT has an excellent technical rating and also presents a decent setup pattern. We see reduced volatility while prices have been consolidating in the most recent period. There is very little resistance above the current price. There is a support zone below the current price at 104.45, a Stop Loss order could be placed below this zone. Very recently a Pocket Pivot signal was observed. This is another positive sign.
A breakout opportunity may arise when the stock surpasses the current consolidation zone and reaches new highs. Traders often wait for this breakout before considering buying the stock. To manage risk, a stop loss order could be placed below the consolidation zone to limit potential losses.
Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents technical observations generated by automated analysis but does not guarantee any trading outcomes. Always trade responsibly and make independent judgments.
Every day, new breakout setups can be found on ChartMill in our Breakout screener.
This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.
NYSE:ABT (2/22/2024, 11:28:09 AM)
The FDA warns of risks associated with using smartwatches or smart rings claiming to measure blood glucose levels without piercing the skin.
In a welcome move, Abbott Laboratories stock saw its Relative Strength Rating improve from 67 to 73 on Wednesday.
Top S&P500 movers in Tuesday's session
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Tuesday.
The market can be a tricky place. Bet on these cash cow stocks to help restore confidence and extract steady returns.
Medtronic is set to report its Q3 FY24 results, with high expectations following strong performances from its peers in the MedTech sector. Read more here.
These stocks reward you during any market environment.
Abbott Laboratories (ABT) declares $0.55/share quarterly dividend, in line with previous. Forward yield 1.92% Payable May 15; for shareholders of record April 1
/PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 55 cents per share. This marks the 401st consecutive...
An FDA advisory panel has voted in favor of Abbott's (ABT) TriClip heart valve device for treating tricuspid regurgitation. Read more here.